VIR BIOTECHNOLOGY INC (VIR:NASDAQ)
$8.85 0.05 (0.5682%)
Analysed VIR BIOTECHNOLOGY INC (VIR:NASDAQ) News Sources
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
17-05-2026
fool.com
Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million
18-05-2026
fool.com
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
23-05-2026
fool.com
How SOLSTICE Phase 2 HDV Data at Vir Biotechnology (VIR) Has Changed Its Investment Story
24-05-2026
yahoo.com
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
07-06-2026
yahoo.com
Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
10-06-2026
yahoo.com
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
26-06-2026
yahoo.com
Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
03-07-2026
yahoo.com
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
22-07-2026
yahoo.com
Vir Biotechnology Announces Chief Financial Officer Transition
24-07-2026
yahoo.com
What is the current price of VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The current price of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is $8.85.
VIR BIOTECHNOLOGY INC (VIR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) since the previous trading day is $0.05.
VIR BIOTECHNOLOGY INC (VIR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIR BIOTECHNOLOGY INC (VIR:NASDAQ) since the previous trading day is 0.5682%.
What is the most recent average sentiment score for VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The most recent average sentiment score for VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for VIR BIOTECHNOLOGY INC (VIR:NASDAQ)?
The most recent sentiment for VIR BIOTECHNOLOGY INC (VIR:NASDAQ) is .
SEC-8K** Filing Available For VIR BIOTECHNOLOGY INC (VIR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.